Last updated July 31, 2026. Case counts change daily — live-tracking links are at the bottom of this article.
If you've seen "Ebola" trending in the news again this summer, you're not imagining it. A new Ebola outbreak has been spreading across the Democratic Republic of the Congo (DRC) and Uganda since May 2026, and it's already one of the largest on record. Here's what's actually happening, how serious it really is, and — since odds are you're reading this from the U.S. — exactly what it means for you.
Quick Answer
- Where: Mainly Ituri Province in northeastern DRC, with spread to North Kivu, Kinshasa, and Kampala, Uganda
- What: Ebola disease caused by the Bundibugyo virus — a rarer, distinct species of Ebola with no approved vaccine or treatment
- Scale: Over 3,300 confirmed cases and nearly 1,500 deaths in DRC alone as of late July 2026, plus additional cases in Uganda. The World Health Organization has declared it a Public Health Emergency of International Concern (PHEIC)
- Risk in the U.S.: The CDC continues to rate the risk to the U.S. public as low. No case connected to this outbreak had been confirmed on U.S. soil as of CDC's latest clear update
- What's changed for travelers: The U.S. has entry screening and temporary entry restrictions for anyone recently in DRC, Uganda, or South Sudan, routed through a handful of designated airports
What's Actually Happening
On May 15, 2026, the DRC's Ministry of Health confirmed a new Ebola outbreak in Ituri Province — the country's 17th, arriving just five months after its previous outbreak ended. Two days later, the World Health Organization declared it a Public Health Emergency of International Concern, its highest level of global alert.
What makes this outbreak unusual isn't just its size — it's the virus itself. Most people picture the Ebola species behind the devastating 2014–2016 West African epidemic (Zaire ebolavirus). This outbreak is caused by a different, less common relative: the Bundibugyo virus. Unlike Zaire ebolavirus, Bundibugyo has no licensed vaccine and no approved treatment, which is part of why health authorities have responded so aggressively.
The outbreak spread quickly from Ituri into North Kivu province, the capital Kinshasa, and across the border into Uganda's capital, Kampala. According to the CDC, confirmed cases in Uganda have so far stayed limited to travel-linked cases in Kampala, without evidence of ongoing community spread inside the country.
The Numbers So Far
Case counts are updated daily by DRC's Ministry of Health, the WHO, and the CDC, so treat any figure — including these — as a snapshot rather than the final word. As of the most recent DRC government report (data through July 27, 2026):
- 3,360 confirmed cases and 1,487 deaths in the DRC
- 733 patients currently hospitalized in isolation
- 597 patients have recovered
- Additional confirmed cases have been reported in Uganda, plus isolated cases in people evacuated for treatment to France and Germany
Based on those cumulative DRC figures, roughly 4 in 10 confirmed patients have died — consistent with the 25–50% fatality range cited for the two previous Bundibugyo virus outbreaks on record, though still lower than the up to 90% fatality rate reported in the worst Zaire ebolavirus outbreaks.
The speed of spread is also notable. The CDC has pointed out that this outbreak passed 1,000 confirmed cases within about 40 days of the response starting — compared to roughly 235 days for the 2018 North Kivu outbreak to hit the same mark.
Why Bundibugyo Virus Changes the Response
There are actually several distinct viruses that cause Ebola disease, each named for where they were first identified: Zaire, Sudan, Bundibugyo, Taï Forest, and Reston. They're related but not identical, and treatments developed for one don't automatically work on the others.
That's the core problem here. Ervebo, the FDA-approved Ebola vaccine, protects against Zaire ebolavirus — the strain most people associate with "Ebola" — but a study in monkeys suggested it may only be partially effective against Bundibugyo virus. The WHO has judged the evidence insufficient to recommend using it in this outbreak. There's also no approved antiviral or antibody treatment for Bundibugyo virus specifically, which is why supportive care — fluids, oxygen, treating symptoms and complications early — remains the main tool doctors have.
How Ebola Actually Spreads — and How It Doesn't
A lot of fear around Ebola comes from misunderstanding how it's transmitted. It's worth being precise:
Ebola spreads through:
- Direct contact with the blood, vomit, or other bodily fluids of a person who is sick with or has died from Ebola
- Contact with contaminated surfaces or materials, like bedding or medical equipment
- Contact with infected animals — fruit bats are the suspected natural reservoir of the virus
Ebola does not spread through:
- Air (it is not airborne, like flu or measles)
- Water
- Casual contact, like sitting near someone or being in the same room
- Food, other than bushmeat from infected animals in affected regions
This is also why it's containable with the right protocols: isolating sick patients and safely managing burials breaks the chain of transmission.
Symptoms to Know
Early symptoms are easy to mistake for the flu or malaria, which is part of what makes outbreaks hard to catch early:
- Sudden fever, chills, and severe weakness
- Muscle and joint pain, headache
- Sore throat
As the disease progresses, it can include:
- Nausea, vomiting, and diarrhea (sometimes with blood)
- Loss of appetite
- In severe cases, unexplained bleeding or bruising
Symptoms typically appear 2 to 21 days after exposure. Anyone with these symptoms who has recently been in an affected area should seek medical care immediately and tell the provider about their travel history before arriving, so the facility can take the right precautions.
So — Is There Any Real Risk to People in the U.S.?
This is the question most U.S. readers actually want answered, so let's be direct about it.
The CDC has consistently rated the risk to the general U.S. public as low, and that assessment hasn't changed. As of CDC's most recent clear public update on this specific question (June 17, 2026), no Ebola case connected to this outbreak had been confirmed inside the United States.
Two American citizens have been infected — both humanitarian aid workers who contracted the virus while working in DRC, in May and July 2026. Neither was brought back to the U.S. for treatment; both were medically evacuated to hospitals in Germany, and neither case led to any spread within the United States.
The low-risk assessment isn't just reassurance — it's backed by specifics:
- Ebola isn't airborne, so it doesn't spread the way pandemic-prone respiratory viruses do
- The U.S. has functioning healthcare infrastructure to isolate and treat any imported case, and to trace and monitor contacts
- Entry screening is specifically designed to catch symptomatic travelers from affected countries before they disperse into the community
That said, "low risk" isn't "zero risk," and officials have noted the assessment could shift if the outbreak spreads to other major international travel hubs. This is genuinely a fluid situation — check the live-update links at the bottom of this article rather than treating any single number as final.
What the U.S. Has Actually Done About It
Since May 18, 2026, the CDC, the Department of Homeland Security, and other federal agencies have had layered public health measures in place to keep Ebola from entering the country:
- Entry restrictions: Most non-U.S. citizens who have recently been in DRC, and certain travelers from Uganda or South Sudan, are temporarily barred from entry, with case-by-case humanitarian and law enforcement exceptions. This order is renewed roughly every 30 days — most recently extended on July 13, 2026 — so check CDC.gov for its current status.
- Airport screening: U.S.-bound travelers who've recently been in DRC, Uganda, or South Sudan are routed through a small number of designated airports (reported as Washington Dulles, Atlanta, Houston, and JFK) for temperature checks, health questionnaires, and CDC quarantine station processing.
- 21-day monitoring: Travelers arriving from affected countries are asked to monitor their temperature and symptoms daily and report to local health departments for up to 21 days — the outer bound of Ebola's incubation period.
- Travel health notices: As of the most recent notice, the CDC recommends avoiding non-essential travel to Haut-Uélé, Ituri, North Kivu, and Tshopo provinces in the DRC specifically (its highest advisory level), with a lower-level advisory in place for Uganda generally.
If You've Recently Traveled to DRC, Uganda, or South Sudan
- Expect to be redirected to one of the designated screening airports on your way into the U.S., and build extra time into your itinerary
- Monitor your temperature and watch for symptoms daily for 21 days after leaving the affected country
- If you develop a fever or other symptoms, don't just show up at an ER waiting room — call ahead so the facility can take appropriate precautions, and mention your travel history immediately
- Check the CDC's current list of affected provinces before booking any non-essential travel, since the specific high-risk areas can be updated as the outbreak evolves
Frequently Asked Questions
Is there an Ebola outbreak in the U.S. right now? No. The outbreak is in the Democratic Republic of the Congo and Uganda. The U.S. has screening and entry measures in place for travelers from those countries, but no case connected to this outbreak had been confirmed on U.S. soil as of CDC's latest clear update.
Is Ebola airborne? No. It spreads through direct contact with the blood or bodily fluids of an infected person or animal, not through the air, water, or casual contact.
Is it safe to travel to Africa right now? It depends entirely on where. The CDC's highest-level advisory applies to specific provinces in the DRC (Haut-Uélé, Ituri, North Kivu, and Tshopo), not the entire continent or even the entire country. Most of Africa, including most of the DRC and Uganda themselves, isn't under any Ebola-related travel advisory.
Is there a vaccine for this Ebola outbreak? Not one that's confirmed effective. The approved Ebola vaccine (Ervebo) targets a different species, Zaire ebolavirus. Evidence on whether it protects against the Bundibugyo virus causing this outbreak is limited, and the WHO hasn't recommended its use here.
How does this compare to the 2014–2016 West Africa Ebola epidemic? That epidemic was caused by Zaire ebolavirus and killed over 11,000 people, mostly in Guinea, Liberia, and Sierra Leone, over about two years. This outbreak involves a different virus species (Bundibugyo), has grown faster in its first weeks than past outbreaks, and — unlike 2014–2016 — has no vaccine available that's confirmed to work against it.
What should I do if I have symptoms after traveling from an affected area? Call a healthcare provider or your local health department before going in person, and clearly state your recent travel history. Early isolation protects both you and the people around you, and it's also the fastest way to rule other, far more common illnesses in or out.
Where to Get Verified, Real-Time Updates
Because this situation changes daily, treat this article as a starting point, not a live feed. For the latest numbers and guidance, go directly to:
- CDC – Ebola Outbreak: Current Situation
- CDC – Ebola and Bundibugyo Virus FAQ
- CDC – Information for Travelers Returning from Ebola-Affected Areas
- WHO – Disease Outbreak News
- ECDC – Ebola Outbreak in DRC and Uganda
This article is for general information only and isn't medical advice. If you're concerned about symptoms or possible exposure, contact a healthcare provider or your local health department directly. Figures in this piece reflect official reporting as of July 31, 2026, and will change as the outbreak continues.
